No presentations found
We’ll display presentations we find for Cadrenal Therapeutics here
ENTITY
Cadrenal Therapeutics (CVKD US)
Cadrenal Therapeutics (CVKD US)
2
Analysis
Health Care • United States
Cadrenal Therapeutics, Inc. operates as a biotech company. The Company focuses on developing tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease, or ESRD, and atrial fibrillation. Cadrenal Therapeutics serves customers worldwide.
more
x